Women with average cholesterol levels who have already experienced heart attacks can reduce their chances of repeat coronary problems through the aid of a new cholesterol-lowering drug, according to a study in July’s Journal of the American College of Cardiology. “Women with (a heart attack) show strong, early reductions in recurrent coronary events during therapy with pravastatin, despite having average cholesterol levels before treatment,” commented researchers.
According to the study, women taking pravastatin for just one year saw a 55 percent reduced risk of major coronary episodes, including heart attacks and stroke.
